NASA moved quickly to tap United Launch Alliance to help fill in the blank space the agency created when it decided to alter ...
New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results